Bronchiectasis
USMLE Step 1 trap: Confuses ground-glass opacities with the signet ring sign as the defining CT feature of bronchiectasis. The hallmark CT finding of bronchiectasis is airway diameter greater than its accompanying pulmonary artery ('signet ring sign') with lack of normal tapering.
Bronchiectasis is permanent, abnormal dilation of the bronchi caused by chronic inflammation and destruction of the airway wall, and on USMLE Step 1 it shows up in two main ways. The key word is *permanent* — unlike reversible bronchospasm, these airways are structurally remodeled and can't go back. Either as a pathological consequence of an underlying disease (CF, Kartagener, ABPA, recurrent infections), or as the diagnosis you need to reach from a clinical vignette describing chronic productive cough with copious purulent sputum and recurrent pneumonias. The CT finding — a dilated bronchus wider than its accompanying artery — is the anchor, and students reliably miss it.
The tricky part of this topic is that bronchiectasis is rarely the primary diagnosis on Step 1 — it's the downstream consequence that reveals the real underlying condition. A teenager with bronchiectasis, situs inversus, and infertility points to Kartagener. A young adult with bronchiectasis plus asthma and peripheral eosinophilia points to ABPA. A child with recurrent Pseudomonas infections and failure to thrive points to CF. Your job is to recognize bronchiectasis as a clue, not the endpoint. Students who memorize bronchiectasis in isolation miss the layered clinical reasoning the exam rewards.
Two consistent pitfalls show up here. First, students confuse the CT findings — ground-glass opacities are for interstitial processes, not bronchiectasis. The signet ring sign (bronchus larger than its artery) with lack of normal airway tapering is the defining image finding. Second, ABPA gets misclassified as invasive infection when it's actually a hypersensitivity reaction — a distinction that completely flips the treatment. USMLE Step 1 loves testing whether you know to reach for steroids, not antifungals, as first-line for ABPA.
Common misconceptions
What the exam tests
- Understand the mechanism of bronchiectasis — chronic inflammation destroying airway walls — and identify the hallmark CT finding (signet ring sign: bronchial diameter exceeding the adjacent pulmonary artery, with loss of normal tapering).
- Recognize the major causes of bronchiectasis and match each etiology to its clinical context: CF in young patients, Kartagener in patients with situs inversus and infertility, ABPA in asthmatics with eosinophilia, and post-infectious causes following severe or recurrent pneumonias.
- Identify Kartagener syndrome by its full clinical tetrad — bronchiectasis, situs inversus, chronic sinusitis, and infertility in both males AND females — and link it to the underlying dynein arm defect causing impaired ciliary motility.
- Distinguish ABPA from invasive aspergillosis: recognize the type I/III hypersensitivity mechanism, the diagnostic profile (elevated IgE, Aspergillus-specific IgE/IgG, peripheral eosinophilia, central bronchiectasis on CT), and the treatment hierarchy (systemic corticosteroids first, itraconazole as adjunct).
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →